| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $15.3M | -33.5% |
| Cost of Revenue | $7.6M | -39.1% |
| Gross Profit | $7.7M | -26.9% |
| R&D Expense | $3.1M | +9.7% |
| SG&A Expense | $11.8M | +5.4% |
| Operating Income | -$7.2M | -105.9% |
| Income Tax | $0 | — |
| Net Income | $29.3M | +151.0% |
| EPS (Basic) | $0.90 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.8M | +2.9% |
| Accounts Receivable | $6.5M | +426.8% |
| Current Assets | $18.5M | +46.2% |
| Total Assets | $19.5M | +42.1% |
| Current Liabilities | $6.3M | +11.1% |
| Total Liabilities | $26.6M | -60.1% |
| Stockholders' Equity | -$7.1M | +86.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.0M | -23.1% |
| Financing Cash Flow | $8.3M | -43.5% |
| +138.5% |
| EPS (Diluted) | $0.76 | +132.5% |